Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123288883 | 12328888 | 3 | F | 201604 | 20160811 | 20160503 | 20160823 | EXP | US-ELI_LILLY_AND_COMPANY-US201604009158 | ELI LILLY AND CO | 66.62 | YR | F | Y | 86.00000 | KG | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123288883 | 12328888 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 6 U, EACH MORNING | C460618C | 20563 | 6 | IU | INJECTION | QD | |||||
| 123288883 | 12328888 | 2 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 10 U, AT LUNCH | C460618C | 20563 | 10 | IU | INJECTION | ||||||
| 123288883 | 12328888 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 6 U, EACH EVENING | C460618C | 20563 | 6 | IU | INJECTION | QD | |||||
| 123288883 | 12328888 | 4 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 6 U, EACH MORNING | 20563 | 6 | IU | INJECTION | QD | ||||||
| 123288883 | 12328888 | 5 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 10 U, AT LUNCH | 20563 | 10 | IU | INJECTION | |||||||
| 123288883 | 12328888 | 6 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 6 U, EACH EVENING | 20563 | 6 | IU | INJECTION | QD | ||||||
| 123288883 | 12328888 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 8 | C | CRESTAR | 2 | U | 0 | ||||||||||||
| 123288883 | 12328888 | 9 | C | ALTACE | RAMIPRIL | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 10 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 11 | C | NEURONTIN | GABAPENTIN | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 12 | C | OSCAL /07357001/ | 2 | U | 0 | ||||||||||||
| 123288883 | 12328888 | 13 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 14 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 15 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 16 | C | ANTIVERT /00007101/ | MECLIZINE MONOHYDROCHLORIDENIACIN | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 17 | C | APAP CODEINE | 2 | U | 0 | ||||||||||||
| 123288883 | 12328888 | 18 | C | BACLOFEN. | BACLOFEN | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 19 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | U | 0 | |||||||||||
| 123288883 | 12328888 | 20 | C | FOLIC ACID. | FOLIC ACID | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123288883 | 12328888 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123288883 | 12328888 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123288883 | 12328888 | Blood glucose increased | |
| 123288883 | 12328888 | Hallucination | |
| 123288883 | 12328888 | Hyponatraemia | |
| 123288883 | 12328888 | Incorrect product storage | |
| 123288883 | 12328888 | Pain in extremity | |
| 123288883 | 12328888 | Tremor | |
| 123288883 | 12328888 | Trigeminal neuralgia | |
| 123288883 | 12328888 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123288883 | 12328888 | 1 | 201511 | 0 | ||
| 123288883 | 12328888 | 2 | 201511 | 0 | ||
| 123288883 | 12328888 | 3 | 201511 | 0 |